news paper icon

Analyzed News

Bayer halts vilaprisan drug trials due to toxicology data

Bayer said it halted trials testing its experimental uterine fibroids treatment vilaprisan, which it previously expected to generate peak annual sales of more than 1 billion euros ($1.1 billion), citing the risk of side effects. [Source]

Publication Date:


Category: healthNews

Topics: bayer, trials, vilaprisan, experimental, uterine

Source Link:

Related Articles